Related Experiment Video

Updated: Dec 12, 2025

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

28.1K

MAPRE1 promotes cell cycle progression of hepatocellular carcinoma cells by interacting with CDK2

Xing-Hua Liang1, Zheng-Ping Feng1, Fo-Qiu Liu1

  • 1Department of Gastroenterology, Zengcheng District people's Hospital of Guangzhou, Guangzhou, Guangdong, China.

Cell Biology International
|August 10, 2020
PubMed

Insights

Microtubule-associated protein RP/EB family member 1 (MAPRE1) is elevated in hepatocellular carcinoma (HCC), driving tumor growth. Targeting MAPRE1 may offer a new therapy and biomarker for HCC patients responsive to CDK inhibitors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Targeting cyclin-dependent kinases (CDKs) shows therapeutic promise in cancer treatment.
  • CDK inhibitor efficacy is limited in hepatocellular carcinoma (HCC) due to poor understanding of cell cycle regulation and lack of predictive biomarkers.

Purpose of the Study:

  • To investigate the role of microtubule-associated protein RP/EB family member 1 (MAPRE1) in HCC progression.
  • To explore MAPRE1 as a potential therapeutic target and predictive biomarker for HCC.

Main Methods:

  • Analysis of MAPRE1 expression in HCC tissues.
  • Assessment of MAPRE1's impact on HCC cell proliferation and in vitro tumorigenesis.
  • Investigation of the interaction between MAPRE1 and CDK2, including effects on CDK2 phosphorylation.

Main Results:

  • MAPRE1 expression is significantly increased in HCC tissue.
  • Elevated MAPRE1 promotes HCC cell proliferation and enhances in vitro tumorigenesis.
  • MAPRE1 binds to CDK2, leading to hyperphosphorylation of CDK2 at the Thr161 residue.
  • High MAPRE1 expression correlates with poor prognosis in HCC patients.

Conclusions:

  • MAPRE1 plays a crucial role in HCC progression and is associated with poor patient outcomes.
  • Targeting MAPRE1 presents a potential therapeutic strategy for HCC.
  • MAPRE1 expression can serve as a biomarker for stratifying HCC patients who may benefit from CDK inhibitor therapy.
Keywords:
CDKsHCCMAPRE1cell proliferationp-CDK2

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.3K
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.9K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.4K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.6K
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
6.4K
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
129.4K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.1K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
37.9K